(19)
(11) EP 4 104 177 A1

(12)

(43) Date of publication:
21.12.2022 Bulletin 2022/51

(21) Application number: 21711092.3

(22) Date of filing: 12.02.2021
(51) International Patent Classification (IPC): 
G16B 20/30(2019.01)
C12Q 1/68(2018.01)
(52) Cooperative Patent Classification (CPC):
G16B 20/30; C12Q 1/6806
 
C-Sets:
C12Q 1/6806, C12Q 2563/159, C12Q 2563/179, C12Q 2565/514, C12Q 2565/629;
(86) International application number:
PCT/US2021/018020
(87) International publication number:
WO 2021/163611 (19.08.2021 Gazette 2021/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.02.2020 US 202062976270 P
21.02.2020 US 202062979986 P
16.11.2020 US 202063114378 P
14.12.2020 US 202063125331 P

(71) Applicant: 10X Genomics, Inc.
Pleasanton, CA 94588-3260 (US)

(72) Inventors:
  • MAHESHWARI, Arundhati Shamoni
    Pleasanton, California 94588 (US)
  • WANG, Li
    Pleasanton, California 94588 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHODS FOR CHARACTERIZING CELLS USING GENE EXPRESSION AND CHROMATIN ACCESSIBILITY